Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Psoriatic arthropathy

Not yet recruiting

InvestigationalNo placebo

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Sonelokimab

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Investigational

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Regn7508

Contact Research Centre

Sjogren's syndrome

Not recruiting

Investigational

Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Dazodalibep

Contact Research Centre

Sjogren's syndrome

Not recruiting

Investigational

Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Dazodalibep

Contact Research Centre

Obesity

Not recruiting

Investigational

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:BI 456906

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Investigational

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Sonelokimab

Contact Research Centre

Systemic scleroderma

Not recruiting

InvestigationalNo placebo

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Fipaxalparant

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Investigational

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

Systemic scleroderma

Not recruiting

Investigational

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Fipaxalparant

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Registered drugNo placebo

Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Sjogren's syndrome

Not recruiting

Investigational

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Vib1116

Contact Research Centre

Giant cell arteritis

Not recruiting

Registered drug

Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

Find therapies in clinical trials near you – page 2

29 trials match your criteria

Psoriatic arthropathy

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

Atrial fibrillation

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Sjogren's syndrome

Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Sjogren's syndrome

Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Obesity

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Psoriatic arthropathy

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Systemic scleroderma

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Psoriatic arthropathy

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Systemic scleroderma

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Rheumatoid arthritis

Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

Sjogren's syndrome

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Giant cell arteritis

Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.